Entera Bio Ltd. (ENTX)
NASDAQ·Healthcare·Biotechnology
$3.06
-6.13%
Mkt Cap $160.69M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —
NASDAQ·Healthcare·Biotechnology
$3.06
-6.13%
Mkt Cap $160.69M
Buy
2
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —